Imatinib, sold under the brand names Gleevec and Glivec (both marketed worldwide by Novartis) among others, is an oral targeted therapy medication used to treat cancer. [2] Imatinib is a …

2024年12月11日 · Imatinib is used to treat certain types of leukemia, bone marrow disorders, and skin cancer. Includes imatinib side effects, interactions, and indications.

2025年3月1日 · Imatinib is used alone or together with other medicines to treat different types of cancer or bone marrow conditions. It prevents or stops the growth of cancer cells and is called …

2023年6月20日 · Imatinib is a 2-phenylamino-pyrimidine derivative protein that is a medication used to manage and treat chronic myelogenous leukemia, gastrointestinal stromal tumors, and …

IMATINIB (i MAT in ib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat certain leukemias, myelodysplastic syndromes, and other …

Find patient medical information for imatinib oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Imatinib, an oral targeted therapy, inhibits tyrosine kinases specifically BCR-ABL, c-KIT, and PDGFRA. Apart from its remarkable success in CML and GIST, Imatinib benefits various other …

Imatinib mesylate is approved to treat: Acute lymphoblastic leukemia in adults and children that is Philadelphia chromosome positive. In adults, it is used for cancer that has come back or does …

Imatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer …

Imatinib is a targeted therapy. It is used to treat some types of leukaemia, blood disorders and gastro-intestinal stromal tumours called GISTs. What is imatinib? Imatinib is used to treat: …